+61 3 9467 4966
enquiries@cyclotek.com
Menu
Home
Company
About Us
Research Philosophy
Corporate
Time Line History
Brochures
Products
Compounded Products
Product Supply
Contract Manufacturing
Quality System
Logistics
Collaborations
News
Facilities
Corporate
Melbourne – Bundoora
Brisbane – Woolloongabba
Wellington – New Zealand
Melbourne – Parkville
Sydney – Lucas Heights
Sydney – Macquarie University Hospital
News
Categories
Categories
Select Category
Clinical
Company
Latest News
Research
Uncategorized
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Posted on: 10 November 2021
Latest News
read More
Cyclotek invests in new tripartite research hub with Monash University and Life Molecular Imaging.
Posted on: 04 October 2021
Uncategorized
read More
Cyclotek’s journey from lab to first-in-human: bettering cancer diagnostics to improve patient outcomes
Posted on: 08 July 2021
Latest News
read More
A Conversation with Pamela Naidoo-Ameglio from ANSTO on Women In Nuclear
Posted on: 28 June 2021
Latest News
read More
GenesisCare in collaboration with Cyclotek, conducts a 100 patient prospective trial on the use of 18F-DCFPyL (PSR) PET/CT in men with detectable PSA post-prostatectomy.
Posted on: 09 June 2021
Latest News
read More
Cyclotek and AANMS lodge application to MSAC seeking MBS rebate for Australian Prostate Cancer patients.
Posted on: 24 May 2021
Latest News
read More
Page 5 of 10
« First
Previous
...
3
4
5
6
7
...
10
...
Next
Last »
© 2026 Cyclotek. All rights reserved
[contact-form-7 id=”714″ title=”Update Form”]
